S P Vickers

1.3k total citations
15 papers, 987 citations indexed

About

S P Vickers is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Endocrine and Autonomic Systems. According to data from OpenAlex, S P Vickers has authored 15 papers receiving a total of 987 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cellular and Molecular Neuroscience, 4 papers in Molecular Biology and 4 papers in Endocrine and Autonomic Systems. Recurrent topics in S P Vickers's work include Neurotransmitter Receptor Influence on Behavior (6 papers), Regulation of Appetite and Obesity (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). S P Vickers is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (6 papers), Regulation of Appetite and Obesity (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). S P Vickers collaborates with scholars based in United Kingdom, United States and Denmark. S P Vickers's co-authors include G.A. Kennett, Colin T. Dourish, Sharon C. Cheetham, Lynn Webster, A. C. Wyatt, Mike Bickerdike, Thue W. Schwartz, Birgitte Holst, Laura Storjohann and Lars‐Ole Gerlach and has published in prestigious journals such as Endocrinology, British Journal of Pharmacology and Psychopharmacology.

In The Last Decade

S P Vickers

15 papers receiving 952 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S P Vickers United Kingdom 10 390 343 298 268 258 15 987
Traci A. Czyzyk United States 18 582 1.5× 436 1.3× 141 0.5× 582 2.2× 318 1.2× 30 1.5k
Francisco Alén Spain 21 298 0.8× 115 0.3× 401 1.3× 195 0.7× 105 0.4× 47 1.1k
John F. McElroy United States 16 320 0.8× 159 0.5× 315 1.1× 209 0.8× 59 0.2× 26 992
Jesse LoVerme United States 11 411 1.1× 180 0.5× 1.2k 3.9× 428 1.6× 110 0.4× 12 1.7k
Deepali Gupta India 20 166 0.4× 244 0.7× 112 0.4× 252 0.9× 120 0.5× 44 821
I. Jack Magrisso United States 15 70 0.2× 253 0.7× 130 0.4× 224 0.8× 159 0.6× 18 778
Victoria Cano Spain 18 197 0.5× 414 1.2× 48 0.2× 493 1.8× 219 0.8× 36 1.2k
Bharath K. Mani United States 22 148 0.4× 787 2.3× 74 0.2× 563 2.1× 473 1.8× 38 1.2k
Samantha Clark France 13 98 0.3× 215 0.6× 246 0.8× 356 1.3× 78 0.3× 24 768
Silvana‐Yanina Romero‐Zerbo Spain 21 188 0.5× 110 0.3× 414 1.4× 202 0.8× 62 0.2× 30 1.1k

Countries citing papers authored by S P Vickers

Since Specialization
Citations

This map shows the geographic impact of S P Vickers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S P Vickers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S P Vickers more than expected).

Fields of papers citing papers by S P Vickers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S P Vickers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S P Vickers. The network helps show where S P Vickers may publish in the future.

Co-authorship network of co-authors of S P Vickers

This figure shows the co-authorship network connecting the top 25 collaborators of S P Vickers. A scholar is included among the top collaborators of S P Vickers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S P Vickers. S P Vickers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Dedic, Nina, Philip Jones, Éva Hajós‐Korcsok, et al.. (2023). TAAR1 Agonist Ulotaront Improves Glycemic Control and Reduces Body Weight in Rodent Models of Diabetes, Obesity, and Iatrogenic Weight Gain. CNS Spectrums. 28(2). 259–259. 1 indexed citations
2.
Vickers, S P, et al.. (2014). Antidiabetic effects of the Cimicifuga racemosa extract Ze 450 in vitro and in vivo in ob/ob mice. Phytomedicine. 21(11). 1382–1389. 26 indexed citations
3.
Heal, D.J., S P Vickers, David P. Hackett, & Peter H. Hutson. (2013). P.1.g.032 Metabolic effects of lisdexamfetamine in a rat model of human obesity with insulin resistance. European Neuropsychopharmacology. 23. S207–S207. 4 indexed citations
4.
Heal, David J., S P Vickers, David P. Hackett, & Peter H. Hutson. (2013). P.1.g.034 Effect of lisdexamfetamine in a rat model of binge-eating disorder. European Neuropsychopharmacology. 23. S208–S209. 1 indexed citations
5.
Poucher, Simon M., et al.. (2012). Effects of saxagliptin and sitagliptin on glycaemic control and pancreatic β‐cell mass in a streptozotocin‐induced mouse model of type 2 diabetes. Diabetes Obesity and Metabolism. 14(10). 918–926. 45 indexed citations
6.
Fell, Matthew, Keith Dickinson, Kay Marshall, et al.. (2007). The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats. Psychopharmacology. 194(2). 221–231. 52 indexed citations
7.
Holst, Birgitte, Kristoffer L. Egerod, S P Vickers, et al.. (2006). GPR39 Signaling Is Stimulated by Zinc Ions But Not by Obestatin. Endocrinology. 148(1). 13–20. 342 indexed citations
8.
Vickers, S P & G.A. Kennett. (2005). Cannabinoids and the Regulation of Ingestive Behaviour. Current Drug Targets. 6(2). 215–223. 52 indexed citations
9.
Dourish, Colin T., Adams, Karen Benwell, et al.. (2004). Discovery and development of selective 5-HT2C receptor agonists for obesity. Fundamental and Clinical Pharmacology. 18. 127–127. 2 indexed citations
10.
Vickers, S P, Neil Easton, Lynn Webster, et al.. (2003). Oral administration of the 5-HT2C receptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia. Psychopharmacology. 167(3). 274–280. 72 indexed citations
11.
Vickers, S P, Lynn Webster, A. C. Wyatt, Colin T. Dourish, & G.A. Kennett. (2003). Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats. Psychopharmacology. 167(1). 103–111. 183 indexed citations
12.
Vickers, S P, Neil Easton, C Malcolm, et al.. (2001). Modulation of 5-HT2A receptor-mediated head-twitch behaviour in the rat by 5-HT2C receptor agonists. Pharmacology Biochemistry and Behavior. 69(3-4). 643–652. 106 indexed citations
13.
Vickers, S P, Karen Benwell, Richard H. Porter, et al.. (2000). Comparative effects of continuous infusion of mCPP, Ro 60‐0175 and d‐fenfluramine on food intake, water intake, body weight and locomotor activity in rats. British Journal of Pharmacology. 130(6). 1305–1314. 66 indexed citations
14.
Lightowler, Sean, et al.. (2000). Tolerance to the anxiogenic-like effect of mCPP in the rat elevated zero-maze test after subchronic administration. European Neuropsychopharmacology. 10. 354–354. 1 indexed citations
15.
Vickers, S P, Peter G. Clifton, & Colin T. Dourish. (1996). Behavioural evidence thatd-fenfluramine-induced anorexia in the rat is not mediated by the 5-HT1A receptor subtype. Psychopharmacology. 125(2). 168–175. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026